Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS
JRSM Cardiovascular Disease
ISSN 2048-0040 · SAGE Publishing · United Kingdom
JRSM Cardiovascular Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.6 (journal website); fully open access; APC about USD 4,150; median 142 days to acceptance (71 articles, last 24 months); acceptance rate 44.4% (journal website); 36 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
JRSM Cardiovascular Disease is published by SAGE Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiac Imaging and Diagnostics and Cardiovascular Function and Risk Factors, together about 20.1% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
JRSM Cardiovascular Disease is an international, peer-reviewed journal which focuses on the pathology, epidemiology, prevention, treatment, and control of all aspects of cardiovascular diseases. View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS
Editor-in-chief Albert FerroPublisher website
Editorial board by country: 6 in mainland China (about 18%); most named United Kingdom 9, Mainland China 6, Hong Kong, China 6, United States 6, Australia 2 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine6.8%
- Cardiac Imaging and DiagnosticsMedicine6.8%
- Cardiovascular Function and Risk FactorsMedicine6.5%
- Atrial Fibrillation Management and OutcomesMedicine5.7%
- Coronary Interventions and DiagnosticsMedicine5.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5%
- Acute Myocardial Infarction ResearchMedicine4.7%
- Cardiac electrophysiology and arrhythmiasMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.6Publisher website ·
- 5-year impact factor (publisher)
- 1.5Publisher website ·
- h-index
- 27OpenAlex ·
- i10-index
- 76OpenAlex ·
- 2-year mean citedness
- 0.49OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 32.08%LetPub ·
Volume
- Articles per year
- 37LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 286 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 35 | 1 |
| 2025 | 36 | 26 | 26 |
| 2024 | 11 | 11 | 16 |
| 2023 | 5 | 5 | 17 |
| 2022 | 12 | 12 | 104 |
| 2021 | 26 | 26 | 162 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
142 daysMedian, submission to acceptance · P25–P75 82 days – 224 days
- Acceptance to online
- median 21 days (71 articles)
- Submission to online
- median 177 days
- Sample
- 71 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Acceptance rate (publisher)
- 44.4%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to acceptance
- 131 daysPublisher website ·
- Acceptance to publication
- 20 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / GBP 3,043 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted8, with length limits
- case reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research papers Original research into medical issues. 300…main text ≤ 1,000 words
- case reportsCase reports 1000 words plus two tables or figures and up to 10 references.Length not stated
- original researchPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research papers Original research into medical issues. 300…Length not stated
- research articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research papers Original research into medical issues. 300…Length not stated
- research paperPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research papers Original research into medical issues. 300…Length not stated
- research papersResearch papers Original research into medical issues. 3000 words and up to five tables or figures and up to 30 references.Length not stated
- review articlePlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Research papers Original research into medical issues. 300…main text ≤ 3,000 words
- review articlesReview articles Up to 3000 words and 30 references.Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- License & copyright
Manuscript content licensed under Creative Commons Licenses Model summary
Manuscript content on this site is licensed under Creative Commons Licenses.
Source ↗Publisher website ·- Open access Publishing fees and open access
No submission/publication fees; optional OA via Sage Choice for a fee. Model summary
There are no fees payable to submit or publish in this journal. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement …
Source ↗Publisher website ·- Peer review Peer review policy
Peer review identity transparency: Single anonymized. Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publishing
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2048-0040
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JRSM Cardiovascular Disease
What CAS zone is JRSM Cardiovascular Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, JRSM Cardiovascular Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JRSM Cardiovascular Disease?
The journal's website gives an impact factor of 0.6; this is the journal's own figure, as LetPub lists none for it; h-index 27.
How long does peer review take at JRSM Cardiovascular Disease?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 142 days (interquartile range 82–224 days); authors report an average review time of about 12 weeks; the journal's website gives an acceptance rate of 44.4%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JRSM Cardiovascular Disease?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JRSM Cardiovascular Disease based?
Of the 34 board members whose country the journal's board page names, 6 (about 18%) are in mainland China; the countries named most often are United Kingdom (9), Mainland China (6) and Hong Kong, China (6). Counted from the institutions listed on the board page; for reference only.
Which databases index JRSM Cardiovascular Disease?
According to LetPub and DOAJ records, JRSM Cardiovascular Disease is indexed in ESCI.
Is JRSM Cardiovascular Disease open access, and what is the APC?
JRSM Cardiovascular Disease is a fully open-access journal. APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .